Clinical Trial Update: ASP8825 - Study in Patients With Restless Legs Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 study of ASP8825 for restless legs syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• ASP8825

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Restless Legs Syndrome | Phase 2 | Status: COMPLETED